These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 19338974)

  • 21. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial.
    Leighton R; Akermark C; Therrien R; Richardson JB; Andersson M; Todman MG; Arden NK;
    Osteoarthritis Cartilage; 2014 Jan; 22(1):17-25. PubMed ID: 24185114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.
    Arron ST; Neuhaus IM
    J Cosmet Dermatol; 2007 Sep; 6(3):167-71. PubMed ID: 17760694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New indications for Hyaluronic acid of the NASHA-gel-generation--highlights from aesthetical dermatology in clinical daily routine].
    Becker-Wegerich P
    J Dtsch Dermatol Ges; 2008 Dec; 6 Suppl 3():S3-20. PubMed ID: 19138284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.
    Moers-Carpi MM; Tufet JO
    Dermatol Surg; 2008 Feb; 34(2):210-5. PubMed ID: 18093199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of common laser treatments on hyaluronic acid fillers in a porcine model.
    Farkas JP; Richardson JA; Brown S; Hoopman JE; Kenkel JM
    Aesthet Surg J; 2008; 28(5):503-11. PubMed ID: 19083570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bio-Revitalization: Effects of NASHA on Genes Involving Tissue Remodeling.
    Avantaggiato A; Girardi A; Palmieri A; Pascali M; Carinci F
    Aesthetic Plast Surg; 2015 Aug; 39(4):459-64. PubMed ID: 26085225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration.
    Yeom J; Bhang SH; Kim BS; Seo MS; Hwang EJ; Cho IH; Park JK; Hahn SK
    Bioconjug Chem; 2010 Feb; 21(2):240-7. PubMed ID: 20078098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outflow facility in isolated porcine eyes after creation of an intrascleral canal by injection of stabilized hyaluronic acid.
    Mavrakanas N; Shaarawy T
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3759-62. PubMed ID: 19218602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial.
    Taylor SC; Burgess CM; Callender VD
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1653-60. PubMed ID: 19807760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Short Note on Nasha Fever.
    Ganguli S
    Ind Med Gaz; 1914 Dec; 49(12):488. PubMed ID: 29006385
    [No Abstract]   [Full Text] [Related]  

  • 31. Foreword: Introduction to Restylane SubQ, a novel non-animal stabilized hyaluronic acid tissue filler (NASHA).
    Jewell ML
    Aesthet Surg J; 2006; 26(1S):S3. PubMed ID: 19338974
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed hypersensitivity reaction to Restylane ® SubQ.
    O'Reilly P; Malhotra R
    Orbit; 2011 Jan; 30(1):54-7. PubMed ID: 21281083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing treatment outcome with Restylane SubQ: the role of patient selection and counseling.
    Grover R
    Aesthet Surg J; 2006; 26(1S):S18-21. PubMed ID: 19338971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restylane SubQ, a non-animal stabilized hyaluronic acid gel for soft tissue augmentation of the mid- and lower face.
    Verpaele A; Strand A
    Aesthet Surg J; 2006; 26(1S):S10-7. PubMed ID: 19338970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of NASHA and OBT Hyaluronic Acid Gels According to Strength, Flexibility, and Associated Clinical Significance.
    Ohrlund A; Winlof P; Bromee T; Prygova I
    J Drugs Dermatol; 2024 Jan; 23(1):1332-1336. PubMed ID: 38206143
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.